Gadd45g is required for timely Sry expression independently of RSPO1 activity.


Journal

Reproduction (Cambridge, England)
ISSN: 1741-7899
Titre abrégé: Reproduction
Pays: England
ID NLM: 100966036

Informations de publication

Date de publication:
22 04 2022
Historique:
received: 04 11 2021
accepted: 22 03 2022
pubmed: 23 3 2022
medline: 26 4 2022
entrez: 22 3 2022
Statut: epublish

Résumé

Sex determination in mammals is controlled by the dominance of either pro-testis (SRY-SOX9-FGF9) or pro-ovary (RSPO1-WNT4-FOXL2) genetic pathways during early gonad development in XY and XX embryos, respectively. We have previously shown that early, robust expression of mouse Sry is dependent on the nuclear protein GADD45g. In the absence of GADD45g, XY gonadal sex reversal occurs, associated with a major reduction of Sry levels at 11.5 dpc. Here, we probe the relationship between Gadd45g and Sry further, using gain- and loss-of-function genetics. First, we show that transgenic Gadd45g overexpression can elevate Sry expression levels at 11.5 dpc in the B6.YPOS model of sex reversal, resulting in phenotypic rescue. We then show that the zygosity of pro-ovarian Rspo1 is critical for the degree of gonadal sex reversal observed in both B6.YPOS and Gadd45g-deficient XY gonads, in contrast to that of Foxl2. Phenotypic rescue of sex reversal is observed in XY gonads lacking both Gadd45g and Rspo1, but this is not associated with rescue of Sry expression levels at 11.5 dpc. Instead, Sox9 levels are rescued by around 12.5 dpc. We conclude that Gadd45g is absolutely required for timely expression of Sry in XY gonads, independently of RSPO1-mediated WNT signalling, and discuss these data in light of our understanding of antagonistic interactions between the pro-testis and pro-ovary pathways.

Identifiants

pubmed: 35315790
doi: 10.1530/REP-21-0443
pmc: PMC9066659
doi:

Substances chimiques

RSPO1 protein, mouse 0
SOX9 Transcription Factor 0
Sex-Determining Region Y Protein 0
Thrombospondins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

333-340

Subventions

Organisme : Medical Research Council
ID : MC_UP_1502/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_2201/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U142684167
Pays : United Kingdom

Références

Mol Cell Biol. 2001 May;21(9):3137-43
pubmed: 11287618
Dev Biol. 2004 Dec 15;276(2):431-40
pubmed: 15581876
Hum Mol Genet. 2018 Jan 1;27(1):190-198
pubmed: 29145650
Dev Cell. 2012 Nov 13;23(5):1020-31
pubmed: 23102580
Sex Dev. 2014;8(5):199-207
pubmed: 24643063
Trends Cell Biol. 2012 Apr;22(4):220-7
pubmed: 22341196
Dev Biol. 2005 Feb 15;278(2):473-81
pubmed: 15680364
Proc Natl Acad Sci U S A. 2018 May 22;115(21):5474-5479
pubmed: 29735715
Nat Genet. 1995 Jan;9(1):15-20
pubmed: 7704017
Development. 2009 Jan;136(1):129-38
pubmed: 19036799
Mech Dev. 2002 Feb;111(1-2):159-62
pubmed: 11804789
Genes Dev. 2013 Feb 1;27(3):261-73
pubmed: 23388825
Hum Mol Genet. 2014 Jun 1;23(11):3035-44
pubmed: 24452333
Science. 1982 Aug 6;217(4559):535-7
pubmed: 7089579
Nature. 2007 Feb 8;445(7128):671-5
pubmed: 17268471
Hum Mol Genet. 2000 Jun 12;9(10):1553-60
pubmed: 10888606
Development. 2004 Feb;131(4):933-42
pubmed: 14736745
Sci Rep. 2018 Nov 23;8(1):17318
pubmed: 30470800
Sex Dev. 2011;5(6):304-17
pubmed: 22116255
Immunity. 2001 May;14(5):583-90
pubmed: 11371360
Elife. 2020 May 26;9:
pubmed: 32450947
Dev Dyn. 2001 Jun;221(2):201-5
pubmed: 11376487
PLoS Genet. 2019 May 22;15(5):e1007895
pubmed: 31116734
Cell Rep. 2019 Mar 19;26(12):3272-3283.e3
pubmed: 30893600
Nature. 2008 Jun 12;453(7197):930-4
pubmed: 18454134
Endocrinology. 2012 Feb;153(2):913-24
pubmed: 22186409
Wiley Interdiscip Rev Dev Biol. 2012 Nov-Dec;1(6):847-59
pubmed: 23799626
PLoS One. 2013;8(3):e58751
pubmed: 23516551
Dev Cell. 2012 Nov 13;23(5):1032-42
pubmed: 23102581
Proc Natl Acad Sci U S A. 2020 Aug 18;117(33):20015-20026
pubmed: 32759216
PLoS Biol. 2009 Sep;7(9):e1000196
pubmed: 19753101
Genetics. 2020 Feb;214(2):467-477
pubmed: 31836612
Sex Dev. 2016;10(4):167-184
pubmed: 27649556
Mol Cell. 2009 Feb 13;33(3):344-53
pubmed: 19217408
Curr Top Dev Biol. 2019;134:167-194
pubmed: 30999975
Mol Cell Endocrinol. 2018 Dec 15;478:17-31
pubmed: 30040984
J Genet. 2015 Dec;94(4):585-90
pubmed: 26690512
Hum Mol Genet. 2008 May 1;17(9):1264-77
pubmed: 18250098
PLoS Genet. 2017 Jan 3;13(1):e1006520
pubmed: 28045957
Nucleic Acids Res. 2017 Jul 7;45(12):7191-7211
pubmed: 28472341
Mol Reprod Dev. 2006 Aug;73(8):1008-16
pubmed: 16700072
PLoS Genet. 2012;8(12):e1003170
pubmed: 23300469
Biol Reprod. 2015 Aug;93(2):35
pubmed: 26108792
Development. 2014 Jun;141(11):2195-205
pubmed: 24866114
Science. 2018 Jun 29;360(6396):1469-1473
pubmed: 29903884

Auteurs

Nick Warr (N)

Mammalian Genetics Unit, Medical Research Council, Harwell Institute, Oxfordshire, UK.

Pam Siggers (P)

Mammalian Genetics Unit, Medical Research Council, Harwell Institute, Oxfordshire, UK.

Joel May (J)

Mammalian Genetics Unit, Medical Research Council, Harwell Institute, Oxfordshire, UK.

Nicolas Chalon (N)

Mammalian Genetics Unit, Medical Research Council, Harwell Institute, Oxfordshire, UK.

Madeleine Pope (M)

Mammalian Genetics Unit, Medical Research Council, Harwell Institute, Oxfordshire, UK.

Sara Wells (S)

The Mary Lyon Centre, Medical Research Council, Harwell Institute, Oxfordshire, UK.

Marie-Christine Chaboissier (MC)

Université Côte d'Azur, Inserm, CNRS, Institut de Biologie Valrose (iBV), Nice, France.

Andy Greenfield (A)

Mammalian Genetics Unit, Medical Research Council, Harwell Institute, Oxfordshire, UK.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH